These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5361621)

  • 1. Voice in myasthenia gravis.
    Maxwell S; Locke JL
    Laryngoscope; 1969 Nov; 79(11):1902-6. PubMed ID: 5361621
    [No Abstract]   [Full Text] [Related]  

  • 2. The otolaryngologist's role in myasthenia gravis.
    Calcaterra TC; Stern F; Herrmann C; Mulder DG
    Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(2):308-12. PubMed ID: 4582679
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantitative method for the assessment of dysarthrophonia in myasthenia gravis.
    Konstantopoulos K; Christou YP; Vogazianos P; Zamba-Papanicolaou E; Kleopa KA
    J Neurol Sci; 2017 Jun; 377():42-46. PubMed ID: 28477705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Poorer speech... then what?].
    van Harskamp F; van Dongen HR
    Ned Tijdschr Geneeskd; 1990 Apr; 134(17):841-3. PubMed ID: 2338947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of the electrologographic method to the study of speech in myasthenia].
    Chevrie-Muller C
    Rev Neurol (Paris); 1968 Jun; 118(6):559-63. PubMed ID: 5724672
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical course and prognosis of myasthenia gravis].
    Kato Y; Yanagi T; Sobue I
    Shinkei Kenkyu No Shimpo; 1971; 15(4):893-6. PubMed ID: 5168641
    [No Abstract]   [Full Text] [Related]  

  • 7. Waveform window.
    Butler KB
    Am J Electroneurodiagnostic Technol; 2007 Mar; 47(1):53-4. PubMed ID: 17503611
    [No Abstract]   [Full Text] [Related]  

  • 8. Palatal lift prosthesis for treatment of anatomic and neurologic palatopharyngeal insufficiency.
    Gonzalez JB; Aronson AE
    Cleft Palate J; 1970 Jan; 7():91-104. PubMed ID: 5266350
    [No Abstract]   [Full Text] [Related]  

  • 9. Palatal lift prosthesis for treatment of anatomic and neurologic palatopharyngeal insufficiency.
    Gonzalez JB; Aronson AE
    Cleft Palate J; 1970 Jan; 7():91-103. PubMed ID: 5266349
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-seropositive myasthenia gravis.
    Zouvelou V; Kyriazi S; Rentzos M; Belimezi M; Micheli MA; Tzartos SJ; Stamboulis E
    Muscle Nerve; 2013 Mar; 47(3):465-6. PubMed ID: 23322599
    [No Abstract]   [Full Text] [Related]  

  • 11. Geographic opinions on speech impairment in myasthenia gravis.
    D'Alessandro R
    Arch Neurol; 1992 Apr; 49(4):346. PubMed ID: 1558506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia gravis. Otorhinolaryngological considerations].
    Salazar C; De Saa MR; Aparicio M; García B; Casado I
    Acta Otorrinolaringol Esp; 2000; 51(1):92-6. PubMed ID: 10799942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compensation of a sigmatism addentalis as an early symptom of myasthenia gravis].
    Breuninger H
    HNO; 1968 Feb; 16(2):53-4. PubMed ID: 5723074
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of generalized myasthenia gravis in patients with ocular myasthenia gravis.
    Papapetropoulos TH; Ellul J; Tsibri E
    Arch Neurol; 2003 Oct; 60(10):1491-2. PubMed ID: 14568823
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intention and action myoclonus. Analysis of changes in voice and speech].
    Dordain M; Degos CF; Chevrie-Muller C; Lhermitte F
    Folia Phoniatr (Basel); 1975; 27(2):93-105. PubMed ID: 1193505
    [No Abstract]   [Full Text] [Related]  

  • 16. Laryngeal myasthenia gravis: report of 40 cases.
    Mao VH; Abaza M; Spiegel JR; Mandel S; Hawkshaw M; Heuer RJ; Sataloff RT
    J Voice; 2001 Mar; 15(1):122-30. PubMed ID: 12269627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromotor pathologies of speech.
    Canter GJ
    Am J Phys Med; 1967 Feb; 46(1):659-66. PubMed ID: 6023289
    [No Abstract]   [Full Text] [Related]  

  • 18. Myasthenia gravis presenting as dysphagia: clinical considerations.
    Khan OA; Campbell WW
    Am J Gastroenterol; 1994 Jul; 89(7):1083-5. PubMed ID: 8017368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of myasthenia gravis with disorders of thyroid function].
    Apostolski S; Gospavić J; Bugarski-Prokopljević C; Trikić R; Vidaković Z
    Srp Arh Celok Lek; 1982 May; 110(5):593-606. PubMed ID: 7163906
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of psychic disorders accompanying myasthenia gravis (Grandaxin, a new, non-relaxant tranquillizer).
    Szobor A
    Ther Hung; 1975; 23(4):159-63. PubMed ID: 7856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.